Table 1.
Cell Line | Causative Genetic Alteration | Dmr Methylation Analysis | 3C Assay | Ncounter Analysis | ||
---|---|---|---|---|---|---|
IC1 | MEST-DMR | PEG10-DMR | ||||
CTRL1 | + | + | + | + | + | |
CTRL2 | + | + | + | + | + | |
CTRL3 | + | + | + | − | + | |
CTRL4 | + | + | + | − | + | |
CdLS1 |
SMC1A c.2351T > C |
+ | + | + | + | + |
CdLS2 |
SMC1A c.173del16 |
+ | + | + | + | + |
CdLS3 |
SMC1A c.2351T > C |
+ | + | + | − | + |
CdLS4 |
SMC1A c.3497A > C |
+ | + | + | − | + |
CdLS5 |
SMC1A c.2078G > A |
+ | + | + | − | + |
CdLS6 |
NIPBL c.-75_ + 65del |
+ | + | + | + | + |
CdLS7 |
NIPBL c.4253G > A |
+ | + | + | − | + |
CdLS8 |
NIPBL c.231-1_231-2del |
+ | + | + | − | + |
CdLS9 |
NIPBL t(5;15) |
+ | + | + | + | + |
Both controls and patient-derived LCLs were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (EuroClone, Milano, Italy) and antibiotics (antibiotic-antimycotic 100×, EuroClone, Milano, Italy) at 37 °C in 5% CO2.